The U.S. cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to ASCO's fourth annual State of Cancer Care in America report released March 22, 2017.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
The Centers for Medicare & Medicaid Services has extended the data submission deadline for the Electronic Health Record (EHR) reporting mechanism of the 2016 Quality Reporting Document Architecture (QRDA) for the Physician Quality Reporting System (PQRS) program. Individual eligible professionals (EPs), PQRS group practices, qualified clinical data registries (QCDRs), and qualified EHR data submission vendors (DSVs) now have until Friday, March 31 at 8:00 p.m. Eastern Time to submit 2016 EHR data via QRDA.
ASCO recently joined more than 100 medical specialty groups and state medical societies in signing an American Medical Association-led letter urging the Centers for Medicare & Medicaid Services (CMS) and Office of the National Coordinator for Health Information (ONC) to delay requiring 2015 Edition Certified Electronic Health Record Technology (CEHRT) until such technology is widely available—and no sooner than January 2019.
The deadline to submit reconsideration applications for the 2017 Electronic Health Record (EHR) Incentive Program payment adjustment—based on the 2015 reporting period—is Feb. 28, 2017. Applications will not be accepted after the deadline.
ASCO’s "Criteria for High-Quality Clinical Pathways in Oncology," is now featured as a special article in the Journal of Oncology Practice. ASCO developed the 15 inter-related criteria to provide an overarching framework for assessing pathway programs in the United States and to guide stakeholders in assessing the quality, utility and integrity of clinical pathways in oncology.
An American Medical Association (AMA)-led coalition including ASCO and 15 other health care organizations today urged health plans, benefit managers, and other stakeholders to reform utilization management policies, including prior authorization requirements, imposed on medical tests, procedures, devices, and drugs.